Skip to main navigation Skip to search Skip to main content

RENAISSANCE 2: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Nicolo, John-Paul (Partner Investigator (PI))
  • Reutens, David Charles (Partner Investigator (PI))
  • Seneviratne, Udaya (Partner Investigator (PI))
  • D'Souza, Wendyl Jude (Partner Investigator (PI))
  • Cheong, Edmund (Partner Investigator (PI))

Project: Research

Project Details

StatusActive
Effective start/end date25/09/25 → 24/09/27

Keywords

  • Clinical Trial
  • 817P203

Clinical Trial Phase

  • Phase II
  • External Sponsor